Eli Lilly dropped 14.1% even though the drugmaker likewise reported ... for a late-stage study of its potential pill version of the popular weight-loss drug Zepbound. Intel sank 3.1% after Trump ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...